The Foundation for Advanced Therapies
Innovation and Translation in Cell Therapy
About us
We are a world-renowned research company located in Kuopio, Finland, in the heart of Savo. Our mission is to conduct high-level research on the translational field of cell therapy.
We provide an exciting environment for applied research of ATMPs (Advanced Therapy Medicinal Products), discovering, establishing and developing them through Phase I / IIa clinical trials and utilizing some of the most advanced analytical and mechanistic proof-of-principle approaches in the sector.
Publications & news
Cytokines impact natural killer cell phenotype and functionality against glioblastoma in vitro.
Date 28.09.2023
UEF and Ferring Ventures continue collaboration in gene and cell therapy research.
Date 22.11.2021
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification.
Date 26.10.2021
Transcriptomics uncovers substantial variability associated with alterations in manufacturing processes of macrophage cell therapy products.
Date 20.08.2020